Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SUMATRIPTAN SUCCINATE
- Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
- Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
- Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults
- CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
- Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions
- A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.
- Study of NXN 188 for the Treatment of Migraine With Aura
- An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)
- Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions
- Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions
- Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
- Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
- Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
- Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
- Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
- A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
- Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents
- To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
- TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
- A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
- A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
- Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
- Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
- Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
Clinical trials list
click for details